Discovery of Imidazole-Based Inhibitors of
Journal
ACS medicinal chemistry letters
ISSN: 1948-5875
Titre abrégé: ACS Med Chem Lett
Pays: United States
ID NLM: 101521073
Informations de publication
Date de publication:
09 Dec 2021
09 Dec 2021
Historique:
received:
30
09
2021
accepted:
12
11
2021
entrez:
17
12
2021
pubmed:
18
12
2021
medline:
18
12
2021
Statut:
epublish
Résumé
The discovery of new targets for the treatment of malaria, in particular those aimed at the pre-erythrocytic stage in the life cycle, advanced with the demonstration that orally administered inhibitors of
Identifiants
pubmed: 34917261
doi: 10.1021/acsmedchemlett.1c00540
pmc: PMC8667308
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1962-1967Subventions
Organisme : NIAID NIH HHS
ID : R01 AI133633
Pays : United States
Informations de copyright
© 2021 American Chemical Society.
Déclaration de conflit d'intérêts
The authors declare no competing financial interest.
Références
Nat Med. 2020 Oct;26(10):1602-1608
pubmed: 32747827
Malar J. 2017 Jan 13;16(1):26
pubmed: 28086874
Nat Rev Drug Discov. 2015 Jun;14(6):424-42
pubmed: 26000721
Nat Commun. 2017 Sep 5;8(1):430
pubmed: 28874661
N Engl J Med. 2014 Jul 31;371(5):411-23
pubmed: 25075834
Bioorg Med Chem Lett. 2005 Jul 1;15(13):3296-301
pubmed: 15922595
Lancet. 2005 Dec 10;366(9502):2012-8
pubmed: 16338450
ACS Infect Dis. 2021 Mar 12;7(3):518-534
pubmed: 33590753
Lancet Infect Dis. 2021 Aug;21(8):1120-1128
pubmed: 33864801
RSC Med Chem. 2019 Dec 16;11(1):98-101
pubmed: 33479608
Mol Microbiol. 2016 Oct;102(2):349-363
pubmed: 27425827
Nat Commun. 2015 Jul 07;6:7285
pubmed: 26149123
J Med Chem. 2019 Oct 24;62(20):9217-9235
pubmed: 31566384
PLoS Biol. 2014 Mar 04;12(3):e1001806
pubmed: 24594931
Sci Rep. 2019 May 7;9(1):7005
pubmed: 31065005
Microbes Infect. 2012 Aug;14(10):831-7
pubmed: 22613210
Cell Chem Biol. 2020 Jul 16;27(7):806-816.e8
pubmed: 32359426